ArticlePloS one2025

Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease.

Olivier Hermine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.